tiprankstipranks
Trending News
More News >
Viva Biotech Holdings (HK:1873)
:1873
Hong Kong Market

Viva Biotech Holdings (1873) Financial Statements

Compare
1 Followers

Viva Biotech Holdings Financial Overview

Viva Biotech Holdings's market cap is currently HK$3.38B. The company's EPS TTM is HK$0.025; its P/E ratio is 18.96; Viva Biotech Holdings is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 1.99B¥ 2.16B¥ 2.38B¥ 2.10B¥ 696.96M
Gross Profit¥ 687.40M¥ 738.43M¥ 815.68M¥ 650.98M¥ 304.87M
Operating Income¥ 229.67M¥ 192.68M¥ 265.98M¥ 236.90M¥ 112.54M
EBITDA¥ 428.00M¥ 391.01M¥ -89.04M¥ 369.94M¥ -223.89M
Net Income¥ 167.29M¥ -116.11M¥ -528.48M¥ 287.55M¥ -386.88M
Balance Sheet
Cash & Short-Term Investments¥ 941.58M¥ 1.04B¥ 678.57M¥ 800.95M¥ 2.36B
Total Assets¥ 7.05B¥ 7.45B¥ 7.92B¥ 8.04B¥ 8.15B
Total Debt¥ 1.28B¥ 1.90B¥ 2.82B¥ 2.65B¥ 2.97B
Net Debt¥ 342.47M¥ 866.89M¥ 2.14B¥ 1.85B¥ 661.06M
Total Liabilities¥ 3.23B¥ 3.76B¥ 4.32B¥ 4.13B¥ 4.40B
Stockholders' Equity¥ 3.80B¥ 3.69B¥ 3.60B¥ 3.91B¥ 3.76B
Cash Flow
Free Cash Flow¥ 182.32M¥ 195.57M¥ 136.72M¥ -487.35M¥ -549.44M
Operating Cash Flow¥ 373.99M¥ 383.40M¥ 386.05M¥ 77.83M¥ 43.18M
Investing Cash Flow¥ 185.90M¥ 439.17M¥ -372.80M¥ -868.84M¥ -3.85B
Financing Cash Flow¥ -657.76M¥ -429.50M¥ -143.20M¥ -653.16M¥ 5.31B
Currency in CNY

Viva Biotech Holdings Earnings and Revenue History

Viva Biotech Holdings Debt to Assets

Viva Biotech Holdings Cash Flow

Viva Biotech Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis